Skip to main content

Table 2 Odds ratios for the metabolic syndrome (NCEP III) in comparison with the amount of steroid exposure

From: Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study

 

LD/LTE

MD/LTE

 

OR (95% CI)

P value

OR (95% CI)

P value

Crude

1.13 (0.62–2.04)

0.695

1.64 (0.92–2.92)

0.094

Model a

0.998 (0.54–1.83)

0.994

1.37 (0.75–2.48)

0.304

Model b

1.15 (0.61–2.19)

0.670

1.4 (0.72–2.58)

0.340

  1. Crude = uncorrected data. Model a = crude data plus adjustment for age and gender. Model b = model a plus adjustment for markers of disease activity/severity (disease duration, erythrocyte sedimentation rate levels, and health assessment questionnaire). CI, confidence interval; LD/LTE, low-dose/long-term exposure; MD/LTE, moderate-dose/long-term exposure; NCEP III, National Cholesterol Education Programme III; OR, odds ratio.